Holen Sie sich die Stockscreener-App
3.83
10.37%
0.36
Vorhandelsmarkt:
4.68
0.85
+22.19%
Schlusskurs vom Vortag:
$3.47
Offen:
$3.66
24-Stunden-Volumen:
1.25M
Relative Volume:
4.87
Marktkapitalisierung:
$78.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-102.09M
KGV:
-3.6476
EPS:
-1.05
Netto-Cashflow:
$-108.72M
1W Leistung:
+17.85%
1M Leistung:
+9.68%
6M Leistung:
-1.92%
1J Leistung:
-58.82%
1-Tages-Spanne:
$3.4001
$3.90
1-Wochen-Bereich:
$3.3034
$3.90
52-Wochen-Spanne:
$2.2045
$9.486
Dbv Technologies Adr Stock (DBVT) Company Profile
Firmenname
Dbv Technologies Adr
Sektor
Branche
Telefon
33(0)155427878
Adresse
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Vergleichen Sie DBVT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DBVT
Dbv Technologies Adr
|
3.83 | 78.58M | 0 | -102.09M | -108.72M | -1.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.11 | 106.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.59 | 80.61B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
649.26 | 38.82B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
240.55 | 31.03B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.15 | 29.28B | 3.30B | -501.07M | 1.03B | -2.1146 |
Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-04 | Hochstufung | Societe Generale | Hold → Buy |
| 2022-12-16 | Herabstufung | Goldman | Neutral → Sell |
| 2022-05-10 | Herabstufung | Goldman | Buy → Neutral |
| 2021-09-14 | Hochstufung | Societe Generale | Hold → Buy |
| 2021-01-22 | Herabstufung | Societe Generale | Hold → Sell |
| 2020-11-02 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-08-06 | Herabstufung | Societe Generale | Buy → Sell |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-17 | Herabstufung | Stifel | Buy → Hold |
| 2020-01-09 | Hochstufung | Stifel | Hold → Buy |
| 2019-12-16 | Eingeleitet | Citigroup | Buy |
| 2019-09-05 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-06-17 | Eingeleitet | Goldman | Buy |
| 2018-12-20 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-12-20 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2018-12-20 | Herabstufung | Jefferies | Buy → Hold |
| 2018-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2017-10-31 | Hochstufung | Societe Generale | Sell → Hold |
| 2017-10-24 | Herabstufung | Societe Generale | Buy → Sell |
| 2017-10-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2017-06-23 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-16 | Hochstufung | Societe Generale | Hold → Buy |
| 2016-09-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-03 | Eingeleitet | Barclays | Overweight |
| 2015-10-23 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Dbv Technologies Adr Aktie (DBVT) Neueste Nachrichten
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
DBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
StockNews.com Initiates Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World
DBV Technologies Reports Positive Phase 3 Study Results - TipRanks
DBV Technologies announces three-year results from EPITOPE trial - TipRanks
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study - The Manila Times
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Flat for Week - MSN
DBV Technologies (NASDAQ:DBVT) Coverage Initiated at StockNews.com - Defense World
DBV Technologies (NASDAQ:DBVT) Share Price Crosses Below 50 Day Moving AverageWhat's Next? - MarketBeat
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN
European Equities Traded in the US as American Depositary Rise in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Edge Lower in Thursday Trading - MSN
European Equities Traded in US as American Depositary Receipts Tread Water Friday, Up 3% for Week - MSN
European Equities Traded in the US as American Depositary Edge Higher in Thursday Trading - MSN
DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - Defense World
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN
Oil Stocks Lead European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading - MSN
DBV Technologies enhances severance terms for top executives - Investing.com
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading - MSN
DBV Technologies' SWOT analysis: viaskin peanut stock shows promise amid challenges - Investing.com
European Equities Traded in the US as American Depositary Lower in Tuesday Trading - MSN
Financial Survey: Apogee Therapeutics (NASDAQ:APGE) versus DBV Technologies (NASDAQ:DBVT) - Defense World
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading - MSN
Wall Street Poised To Open Lower A Day After Nasdaq's Record Close Above 20,000: Expert Flags 'Deterioration Under The Surface' As 117 S&P 500 Stocks Hit New Monthly Lows - Benzinga
DBV Technologies jumps on US FDA approval of peanut allergy treatment - XM
DBV Confirms Alignment with U.S. FDA on Accelerated - GlobeNewswire
DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 13 Years-Old - The Manila Times
DBV Technologies Secures FDA Fast-Track for Revolutionary Peanut Allergy Patch in Toddlers - StockTitan
DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old - Yahoo Finance
European Equities Traded in the US as American Depositary Tread Water in Friday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading - MSN
DBV Technologies' SWOT analysis: peanut allergy treatment stock faces funding hurdles - Investing.com
DBV Technologies S.A. (NASDAQ:DBVT) Short Interest Down 5.3% in November - MarketBeat
DBV technologies S.A. (ADR) Revenue Breakdown – SWB:DBV1 - TradingView
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Decline in Tuesday Trading - MSN
Dbv technologies chief medical officer sells shares worth $1,269 - Investing.com
European Equities Traded in the US as American Depositary Rise Thursday - MSN
DBV Technologies (STU:DBV0) Shares Outstanding (EOP) : 96.20 Mil (As of Sep. 2024) - GuruFocus.com
DBV Technologies (STU:DBV0) Financial Strength : 7 (As of Sep. 2024) - GuruFocus.com
DBV Technologies (STU:DBV0) 3-Year EBITDA Growth Rate : 29.70% (As of Sep. 2024) - GuruFocus.com
Finanzdaten der Dbv Technologies Adr-Aktie (DBVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dbv Technologies Adr-Aktie (DBVT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mohideen Pharis | Chief Medical Officer |
Nov 22 '24 |
Sale |
0.53 |
342 |
181 |
111,675 |
| Mohideen Pharis | Chief Medical Officer |
Nov 21 '24 |
Sale |
0.54 |
2,350 |
1,269 |
112,017 |
| Mohideen Pharis | Chief Medical Officer |
Jul 29 '24 |
Sale |
0.98 |
1,785 |
1,749 |
79,367 |
| Mohideen Pharis | Chief Medical Officer |
May 24 '24 |
Sale |
1.36 |
660 |
898 |
81,152 |
| Mohideen Pharis | Chief Medical Officer |
May 22 '24 |
Sale |
1.38 |
382 |
527 |
81,812 |
| Tasse Daniel | CHIEF EXECUTIVE OFFICER |
Mar 08 '24 |
Buy |
0.83 |
17,094 |
14,188 |
17,094 |
| Ndu Adora | Director |
Feb 06 '24 |
Buy |
0.89 |
1,825 |
1,624 |
1,825 |
0.08%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):